| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2444794C Technique for extracorporeal treatment of blood |
| 06/19/2007 | CA2287478C Methods for increasing the efficiency of recombinant aav product |
| 06/19/2007 | CA2281830C Methods of commercial production and extraction of protein from seed |
| 06/19/2007 | CA2257304C Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 06/19/2007 | CA2195127C Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 06/19/2007 | CA2189690C Novel active peptide and its preparation |
| 06/19/2007 | CA2185826C Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/19/2007 | CA1341532C Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
| 06/14/2007 | WO2007067923A2 Compositions and methods for detecting phosphomonoester |
| 06/14/2007 | WO2007067896A1 Method for determining vasoreactivity |
| 06/14/2007 | WO2007067683A2 Methods and compositions for expanding t regulatory cells |
| 06/14/2007 | WO2007066775A1 TRANSGENIC FOWL HAVING Gla RESIDUE IN PROTEIN DERIVED FROM FOREIGN GENE |
| 06/14/2007 | WO2007066715A1 Uniaxially oriented hydrogel |
| 06/14/2007 | WO2007066708A1 INDUCTION OF HARD TISSUE FORMATION RELYING ON Wnt5a/SFRP4 SIGNAL SYSTEM |
| 06/14/2007 | WO2007066484A1 Method for determination of stress, marker for use in determination of stress, diagnostic agent for determination of stress, and stress determination system |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007066124A1 Cys-rich, cell surface glycoproteins |
| 06/14/2007 | WO2007066018A2 Novel peptides and the biological use thereof |
| 06/14/2007 | WO2007065967A1 A vaccine suitable for use against the next influenza a pandemia |
| 06/14/2007 | WO2007065957A2 Methods for generating antigen-specific effector t cells |
| 06/14/2007 | WO2007065918A2 Method for purifying fsh or a fsh mutant |
| 06/14/2007 | WO2007065812A1 Process for the preparation of ferri-succinylcasein |
| 06/14/2007 | WO2007065690A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/14/2007 | WO2007065635A1 Polypeptides |
| 06/14/2007 | WO2007065464A1 Epidermal growth factor (egf) derivatives with selectable selectivity for the erb receptor family |
| 06/14/2007 | WO2007065265A1 Cross-linking reagents for hemoglobin and hemoglobin products cross-linked therewith |
| 06/14/2007 | WO2007065215A1 Treatment of epstein-barr virus-associated diseases |
| 06/14/2007 | WO2007045247A3 Fibroblast growth factor receptor-derived peptides |
| 06/14/2007 | WO2007044406A3 Methods for stimulating an immune response using bacterial antigen delivery system |
| 06/14/2007 | WO2007039788A8 Composition and methods for inhibiting h. pylori adhesion and infection |
| 06/14/2007 | WO2007038407A3 Compositions and methods for treating nervous system disorders |
| 06/14/2007 | WO2007027640A3 Stabilized virus-like particles and epitope display systems |
| 06/14/2007 | WO2007024628A3 Ply-gbs mutant lysins |
| 06/14/2007 | WO2007020617A9 Sequences of megaplasmid pmp118, chromosomal sequences and individual sequences thereof of lactobacillus salivarius strain ucc118 |
| 06/14/2007 | WO2007019411A3 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 06/14/2007 | WO2007007147A3 Novel bacterial proteins with pesticidal activity |
| 06/14/2007 | WO2006120580A3 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 06/14/2007 | WO2006113614A3 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 06/14/2007 | WO2006113372A3 Porcine circovirus and helicobacter combination vaccines |
| 06/14/2007 | WO2006109192A3 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 06/14/2007 | WO2006096473A3 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 06/14/2007 | WO2006073889A3 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 06/14/2007 | WO2006069181A3 Compositions and methods for promoting wound healing and tissue regeneration |
| 06/14/2007 | WO2006048768A8 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 06/14/2007 | WO2006044839A9 Increased wax production in plants |
| 06/14/2007 | WO2005016236A3 Antibodies that immunospecifically bind to trail receptors |
| 06/14/2007 | WO2005003306A3 Sppls as modifiers of the p53 pathway and methods of use |
| 06/14/2007 | WO2004032847A3 Hepatocyte growth factor variants |
| 06/14/2007 | US20070136896 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein |
| 06/14/2007 | US20070136893 Control of fruit dehiscence in plants by indehiscent1 genes |
| 06/14/2007 | US20070136889 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070136825 Fusion proteins useful for detecting analytes |
| 06/14/2007 | US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 06/14/2007 | US20070135619 Production of a von willebrand factor prepartion having a great specific activity |
| 06/14/2007 | US20070135618 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 06/14/2007 | US20070135514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/14/2007 | US20070135365 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby |
| 06/14/2007 | US20070135349 Method for increasing the serum half-life of a biologically active molecule |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/14/2007 | US20070135346 Prodrugs of CC-1065 analogs |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135342 Modified Factor VIII |
| 06/14/2007 | US20070135340 IGF-1 novel peptides |
| 06/14/2007 | US20070135339 Bacteriocin inducer peptides |
| 06/14/2007 | US20070135338 Human GLP-1 mimetibodies, compositions, methods and uses |
| 06/14/2007 | US20070135337 Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
| 06/14/2007 | US20070135336 Follistatin isoforms and uses thereof |
| 06/14/2007 | US20070135335 Therapeutic molecules |
| 06/14/2007 | US20070135334 Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
| 06/14/2007 | US20070134802 Ionization modifier for mass spectrometry |
| 06/14/2007 | US20070134764 Endogenous and non-endogenous version of human G protein-coupled receptors |
| 06/14/2007 | US20070134761 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 06/14/2007 | US20070134757 Method for cleaving proteins |
| 06/14/2007 | US20070134749 Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase |
| 06/14/2007 | US20070134746 Using concentration of iron regulating polypeptide to detect blood disorders; immunoassay |
| 06/14/2007 | US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders |
| 06/14/2007 | US20070134737 Fluorophore compounds and their use in biological systems |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134727 Antibodies to cytokine receptor |
| 06/14/2007 | US20070134723 Compositions and methods for detecting phosphomonoester |
| 06/14/2007 | US20070134704 Expression vector comprising nucleotide sequences coding fluorescent neurofilament protein (NFP) for diagnostic imaging tool in molecular genetics |
| 06/14/2007 | US20070134703 Chromophores/fluorophores and methods for using the same |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134680 Lipid metabolism molecules |
| 06/14/2007 | US20070134664 Human autism susceptibility gene and uses thereof |
| 06/14/2007 | US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
| 06/14/2007 | US20070134648 Affinity-based enrichment of phosphorylated peptides and/or proteins |
| 06/14/2007 | US20070134647 Material for promoting the freezing of water or hydrous substance |
| 06/14/2007 | US20070134272 Mannheimia haemolytica chimeric outer membrane protein PIpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever |
| 06/14/2007 | US20070134270 Chicken rna polymerase i promoter and the use thereof |
| 06/14/2007 | US20070134267 Tuberculosis vaccine with improved efficacy |
| 06/14/2007 | US20070134263 Grampositive immunogen protein for use in developing vaccine for prevention of microorganismal infection; immunization |
| 06/14/2007 | US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus |
| 06/14/2007 | US20070134261 Effectors of innate immunity |